Amgen Inc.
BCMA antigen binding proteins
Last updated:
Abstract:
The present invention relates to BCMA (B-Cell Maturation Antigen) antigen binding proteins, such as antibodies, polynucleotide sequences encoding said antigen binding proteins, and compositions and methods for diagnosing and treating diseases. The present invention also relates to BCMA antibody drug conjugates and uses thereof.
Status:
Grant
Type:
Utility
Filling date:
5 Dec 2013
Issue date:
5 Nov 2019